Genes involved in DNA methylation (such as TET2 and DNMT3A) were frequently mutated in biCEBPA mutated AML, especially in the older participants and mutated TET2 was not significantly different from wild type in relapse/event-free survival (6, 36). The gene discussed is TET2; the disease is acute myeloid leukemia.